US Federal Trade Commission: FTC approves Actavis's acquisition of Warner Chilcott with conditions
MLex Summary: The US Federal Trade Commission has approved pharmaceutical company Actavis's $8.5 billion buyout of Warner Chilcott contingent on the sale of rights and assets of four generic pharmaceuticals --...To view the full article, register now.
Already a subscriber? Click here to view full article